On Monday, PDS Biotechnology Corporation (NASDAQ: PDSB) was -5.62% drop from the session before, before settling in for the closing price of $1.02. A 52-week range for PDSB has been $0.85 – $4.03.
Healthcare Sector giant saw their annual sales surged by 6.42% over the last five years. When this article was written, the company’s average yearly earnings per share was at 20.71%. With a float of $45.25 million, this company’s outstanding shares have now reached $46.63 million.
The firm has a total of 24 workers. Let’s measure their productivity.
PDS Biotechnology Corporation (PDSB) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward PDS Biotechnology Corporation stocks. The insider ownership of PDS Biotechnology Corporation is 3.78%, while institutional ownership is 15.85%. The most recent insider transaction that took place on Feb 28 ’25, was worth 25,000. In this transaction Director of this company bought 15,060 shares at a rate of $1.66, taking the stock ownership to the 61,213 shares. Before that another transaction happened on Feb 28 ’25, when Company’s Director bought 15,061 for $1.66, making the entire transaction worth $25,001. This insider now owns 78,851 shares in total.
PDS Biotechnology Corporation (PDSB) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.29 earnings per share (EPS) during the time that was less than consensus figure (set at -0.28) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.84% during the next five years compared to 6.42% growth over the previous five years of trading.
PDS Biotechnology Corporation (NASDAQ: PDSB) Trading Performance Indicators
You can see what PDS Biotechnology Corporation (PDSB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.92, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.73 in one year’s time.
Technical Analysis of PDS Biotechnology Corporation (PDSB)
Analysing the last 5-days average volume posted by the [PDS Biotechnology Corporation, PDSB], we can find that recorded value of 0.47 million was lower than the volume posted last year of 0.54 million. As of the previous 9 days, the stock’s Stochastic %D was 13.11%.
During the past 100 days, PDS Biotechnology Corporation’s (PDSB) raw stochastic average was set at 0.26%, which indicates a significant decrease from 0.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0539 in the past 14 days, which was lower than the 0.0948 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1437, while its 200-day Moving Average is $1.3302. Now, the first resistance to watch is $1.0151. This is followed by the second major resistance level at $1.0674. The third major resistance level sits at $1.0949. If the price goes on to break the first support level at $0.9353, it is likely to go to the next support level at $0.9078. Should the price break the second support level, the third support level stands at $0.8555.
PDS Biotechnology Corporation (NASDAQ: PDSB) Key Stats
There are 47,026K outstanding shares of the company, which has a market capitalization of 45.27 million. As of now, sales total 0 K while income totals -37,610 K. Its latest quarter income was 0 K while its last quarter net income were -9,430 K.
